MODERATOR(S)
Kent Mouw, MD, PhD - Dana-Farber Cancer Institute
David Yu, MD, PhD, FASTRO - Emory University
session DESCRIPTION
Quick Pitch sessions provide opportunities for presenters to summarize outcomes while highlighting key takeaways from their research in a fast-paced format to present concise takeaways.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
| CAMPEP Credits: | 1.00 |
| MDCB Credits: | 1.00 |
Presentations
-
09:15am - 09:20am ETSpeaker: Kent Mouw, MD, PhD - Dana-Farber Cancer Institute, Boston
-
09:15am - 10:15am ETSpeaker: Kent Mouw, MD, PhD - Dana-Farber Cancer Institute, Boston
-
09:15am - 10:15am ETSpeaker: David Yu, MD, PhD, FASTRO - Emory University, Atlanta
-
09:20am - 09:25am ETSpeaker: Rongli Xu, MS - Department of Radiation Oncology Cancer Institute & Hospital, Chinese Academy of Medical Science, Beijing
-
09:25am - 09:30am ET
AKR1C3 Negatively Regulates the LGALS3/p62/NRF2 Axis to Inhibit Ferroptosis and Induce Radioresistance in Prostate Cancer
Speaker: Feng Lyu, MD, PhD - Peking University First Hospital, Beijing -
09:30am - 09:35am ET
Radiation Modulates HER2 Expression and Trastuzumab Deruxtecan Response in HER2-Low Metastatic Breast Cancer
Speaker: Qing Li, MD, PhD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland -
09:35am - 09:40am ET
Nanoray Pancreas: Biomarker Insights of NBTXR3 Activated by Radiotherapy (RT) for Locally Advanced or Borderline Resectable Pancreatic Cancer (LAPC or BRPC)
Speaker: Kasey Cargill, MD, PhD - MD Anderson Cancer Center, Houston -
09:40am - 09:45am ET
AARS1/2-Mediated Histone Lactylation Drives an Immunosuppressive Tumor Microenvironment and Represents a Novel Target to Enhance Anti-PD-1 Therapy
Speaker: Rong Xiao, PhD - Shandong Cancer Hospital and Institute, Jinan -
09:45am - 09:50am ETSpeaker: Yajie Sun, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan
-
09:50am - 10:10am ETSpeaker: David Yu, MD, PhD, FASTRO - Emory University, Atlanta
-
10:10am - 10:15am ETSpeaker: Kent Mouw, MD, PhD - Dana-Farber Cancer Institute, Boston